Oral Answers to Questions

Douglas Carswell Excerpts

Wednesday 16th November 2016 Commons Chamber

[The Prime Minister]

I absolutely join my hon. Friend, who raises a very important issue, in commending such events. It true that the DOH, Public Health England and the NHS are doing vital work to decrease infection rates. We have already seen some very good results—a 57% reduction in MRSA bloodstream infections since 2010 and a 47% reduction in C. diff infections—but of course there is more to do, which is why we are setting bold objectives to halve gram-negative blood infections by 2020, and why last week we announced a new national infection lead to champion and oversee this effort. This is an important issue and I am grateful to my hon. Friend for raising it.

[Mr Douglas Carswell (Clacton) (UKIP)]

Q3. Free trade is vital to our future prosperity, and Brexit does not mean rejecting globalisation. Will the Prime Minister ensure that any new trade deals with the wider world after Brexit are based on the mutual recognition of standards, not on the kind of over-elaborate, prescriptive, top-down regulatory regime that underpins the European single market?

[The Prime Minister]

I welcome the hon. Gentleman’s support for free trade. He is absolutely right that as we leave the EU we will be looking for opportunities to develop flexible trading relationships around the world that suit the United Kingdom. Given the strength of our economy, I believe that we can go out there and be a global leader in free trade, and I welcome his support for that.